Tenax Therapeutics, Inc.TENXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank93
3Y CAGR+82.5%
5Y CAGR+48.3%
Year-over-Year Change
Research and development spending
3Y CAGR
+82.5%/yr
vs +44.3%/yr prior
5Y CAGR
+48.3%/yr
Recent acceleration
Acceleration
+38.1pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
7.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $32.67M | +157.1% |
| 2024 | $12.71M | +293.6% |
| 2023 | $3.23M | -40.0% |
| 2022 | $5.38M | -78.6% |
| 2021 | $25.15M | +451.4% |
| 2020 | $4.56M | +31.4% |
| 2019 | $3.47M | +180.1% |
| 2018 | $1.24M | -64.9% |
| 2017 | $3.53M | -90.0% |
| 2016 | $35.14M | - |